Latest Daily News

Latest News
June 4, 2017

CENTRA will serve as a hub for ASCO’s data, research, and related analyses.

Read more

June 3, 2017

In 2015, ASCO and AACI led a multi-stakeholder survey to identify and prioritize the most burdensome regulatory and/or administrative aspects of clinical trials: clinical trial contracting, clinical trial coverage analyses and budgeting, and training and regulatory requirements.

Read more
June 1, 2017

This Education Session will look at how to improve efficiencies so that clinical trials run faster and will evaluate why some studies do not enroll patients effectively

Read more
June 1, 2017

Three presenters will discuss strategies for making clinical research more effective and efficient while maintaining patient safety.

Read more
May 25, 2017

As part of ASCO’s efforts to support cancer researchers and research sites, the ASCO Research Community Forum was created in 2010 to help clinical investigators and research staff overcome common barriers to conducting research and enhance their research site operations.

Read more
June 7, 2016

The session “Novel Direction of Clinical Trial Design” addressed some of the issues involved in realizing the promise of immunotherapy. 

Read more

May 26, 2016

Clinical trials remain the backbone of cancer therapies, but participation in trials has remained at low levels for decades. In several Education Sessions, experts will discuss overcoming barriers to clinical trial participation, the importance of Cooperative Group trials, and related topics.

Read more

May 26, 2016

Stakeholders from ASCO and the Association of American Cancer Institutes (AACI) came together last year to develop the ASCO-AACI Best Practices in Cancer Clinical Trials Initiative.

Read more

May 26, 2016

For pioneering several cancer treatment methodologies, Dr. Waun Ki Hong will be honored with the 2016 Special Recognition Award, given to individuals who have had a major influence in the areas of clinical oncology, cancer research, clinical trials, reimbursement, and patient advocacy activities.

Read more
May 22, 2015

Recipients of the 2015 Comparative Effectiveness Research Professorship (CERP) in Breast Cancer and the 2015 Advanced Clinical Research Award (ACRA) in Breast Cancer.

Read more
May 30, 2015

Drs. Beverly A. Teicher, Francisco J. Esteva, and Kathy Miller to present the past, present, and future of antibody-drug conjugates for the management of solid and hematologic malignancies. Their discussion will review past clinical studies and future application in the clinical setting.

Read more
May 29, 2015

Dr. Matthew J. Ellis will receive the ASCO 2015 Gianni Bonadonna Breast Cancer Award and Lecture for his pioneering research into the clinical relevance of activating mutations in HER2 and in the deployment of patient-derived xenografts for the pharmacological annotation of breast cancer genomes.

Read more
May 31, 2015

Plans were announced Monday for ASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR) study and the National Cancer Institute (NCI)-MATCH: Molecular Analysis for Therapy Choice trial (EAY131), two clinical studies which aim to expand the boundaries of precision medicine.

Read more
May 30, 2015

Education session “Enrolling Patients in Early-Phase Clinical Trials: An Ethical Dilemma,” addresses ethical issues in phase I trials, including incorporating older adults into oncology trials.

Read more
May 31, 2015

In patients with previously untreated HER2-positive metastatic breast cancer, T-DM1 appears to be noninferior to trastuzumab plus a taxane but is not superior to HT, and the addition of pertuzumab to T-DM1 offers no efficacy benefit, based on results of the randomized, phase III MARIANNE trial.

Read more
May 31, 2015

One year of neratinib improved the rate of invasive disease-free survival compared to placebo in patients with HER2-positive early breast cancer who had undergone prior adjuvant therapy with chemotherapy and trastuzumab, according to results of the randomized ExteNET trial.

Read more